Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision changed from v3.6.4 to v3.6.5, indicating a small administrative update to the page. This update does not modify the study data or other visible content.
    Difference
    0.1%
    Check dated 2026-08-08T18:25:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Adds the updated document revision v3.6.4 for the study materials and removes the older v3.6.3 version. This reflects an updated protocol and related materials associated with the study on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-07-25T10:40:21.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added, indicating an updated version of the Study Protocol and Statistical Analysis Plan document. The previous revision (v3.6.2) was removed.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a software version update for the site rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no active enrollment. New help sections are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header is updated alongside a revision tag advancing to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T14:08:29.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.5.5 has been added to the page. The previous revision tag Revision: v3.5.4 has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T09:27:17.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.